|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Cardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA (SV-L, LMA, SMJ, and AHL) and the Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland (ATE)
Background: Partially hydrogenated fat has an unfavorable effect on cardiovascular disease risk. Palm oil is a potential substitute because of favorable physical characteristics.
Objective: We assessed the effect of palm oil on lipoprotein profiles compared with the effects of both partially hydrogenated fat and oils high in monounsaturated or polyunsaturated fatty acids.
Design: Fifteen volunteers aged
50 y with LDL cholesterol
130 mg/dL were provided with food for each of 4 diets (35 d/phase) varying in type of fat (partially hydrogenated soybean, soybean, palm, or canola; two-thirds fat, 20% of energy). Plasma fatty acid profiles, lipids, lipoproteins, apolipoprotein A-I, apolipoprotein B, lipoprotein(a), glucose, insulin, HDL subfractions, and indicators of lipoprotein metabolism (HDL-cholesterol fractional esterification rate, cholesteryl ester transfer protein, phospholipid transfer protein, and paraoxonase activities) were measured at the end of each phase.
Results: Plasma fatty acid profiles reflected the main source of dietary fat. Partially hydrogenated soybean and palm oils resulted in higher LDL-cholesterol concentrations than did soybean (12% and 14%, respectively; P < 0.05) and canola (16% and 18%; P < 0.05) oils. Apolipoprotein B (P < 0.05) and A-I (P < 0.05) concentrations mirrored the pattern of LDL- and HDL-cholesterol concentrations, respectively. No significant effect on the total-to-HDL cholesterol ratio was observed for palm oil compared with the other dietary fats. HDL3 cholesterol was higher after palm oil than after partially hydrogenated and soybean oils (P < 0.05). Differences in measures of glucose and HDL intravascular processing attributable to dietary fat were small.
Conclusion: Palm and partially hydrogenated soybean oils, compared with soybean and canola oils, adversely altered the lipoprotein profile in moderately hyperlipidemic subjects without significantly affecting HDL intravascular processing markers.
Key Words: Cardiovascular disease trans fatty acids lipoproteins palm oil partially hydrogenated soybean oil LDL cholesterol HDL cholesterol insulin glucose cholesteryl ester transfer protein phospholipid transfer protein
This article has been cited by other articles:
![]() |
A. Esmaillzadeh and L. Azadbakht Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women Am. J. Clinical Nutrition, October 1, 2008; 88(4): 913 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Damude and A. J. Kinney Enhancing Plant Seed Oils for Human Nutrition Plant Physiology, July 1, 2008; 147(3): 962 - 968. [Full Text] [PDF] |
||||
![]() |
A. Esmaillzadeh and L. Azadbakht Consumption of Hydrogenated Versus Nonhydrogenated Vegetable Oils and Risk of Insulin Resistance and the Metabolic Syndrome Among Iranian Adult Women Diabetes Care, February 1, 2008; 31(2): 223 - 226. [Full Text] [PDF] |
||||
![]() |
A. H Lichtenstein and N. R Matthan The effect of soybean-based foods on plasma lipid and lipoprotein concentrations Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1253 - 1253. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |